Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Elevance Health's Revenue for the
three
months ended in Mar. 2026 was €43,407 Mil. Elevance Health's Total Assets for the quarter that ended in Mar. 2026 was €106,298 Mil. Therefore, Elevance Health's Asset Turnover for the quarter that ended in Mar. 2026 was 0.41.
Asset Turnover is linked to ROE % through Du Pont Formula. Elevance Health's annualizedROE % for the quarter that ended in Mar. 2026 was 16.18%. It is also linked to ROA % through Du Pont Formula. Elevance Health's annualizedROA % for the quarter that ended in Mar. 2026 was 5.74%.
Elevance Health (XTER:A58) Asset Turnover Explanation
Asset Turnover is linked to ROE % through Du Pont Formula.
Elevance Health's annulizedROE % for the quarter that ended in Mar. 2026 is
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.
It is also linked to ROA % through Du Pont Formula:
Elevance Health's annulizedROA % for the quarter that ended in Mar. 2026 is
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.
Elevance Health Asset Turnover Related Terms
Elevance Health Asset Turnover Historical Data
* Premium members only.
The historical data trend for Elevance Health's Asset Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:A58 vs CI, CVS, HUM: Asset Turnover Comparison
For the Healthcare Plans subindustry, Elevance Health's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elevance Health Asset Turnover vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Elevance Health's Asset Turnover distribution charts can be found below:
* The bar in red indicates where Elevance Health's Asset Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.
Elevance Health (XTER:A58) has a Asset Turnover of 0.41 as of Mar. 2026. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Elevance Health and its competitors.
Is Elevance Health's Asset Turnover too high?
Elevance Health's current Asset Turnover is 0.41. Overall, Elevance Health has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's Asset Turnover compare to CI and CVS?
Elevance Health's Asset Turnover of 0.41 can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Healthcare Plans company?
A good Asset Turnover depends on the Healthcare Plans industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Elevance Health and its competitors. Elevance Health's current Asset Turnover is 0.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (XTER:A58) is currently considered Modestly Undervalued. The stock's GF Value™ is €441.91, compared to a current price of €343.40 — trading 22.3% below its estimated fair value. The current Asset Turnover is 0.41. Elevance Health's overall GF Score™ is 89/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Elevance Health (XTER:A58), the current Asset Turnover is 0.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elevance Health (XTER:A58) Overvalued in 2026?
Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued.
The current stock price of €343.40 is trading 22.3% below its estimated GF Value™ of €441.91.
GuruFocus considers Elevance Health to be Modestly Undervalued.
Key valuation signals for XTER:A58:
Asset Turnover: 0.41
GF Value™: €441.91 vs. price of €343.40 (22.3% below fair value)
No single metric tells the full story. See the XTER:A58 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
89GF Score
Get the complete analysis for XTER:A58
Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:A58 has been successfully added to your 
